Reportstack, provider of premium market research reports announces the addition of Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value market report to its offering
Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
Summary
Reportstack, the leading business intelligence provider, has released its latest research “Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value”, which provides insights into metabolic disease therapeutics marled until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the major metabolic diseases including Diabetes, Obesity and Dyslipidemia. The report also provides the share of generics in global metabolic diseases as well as in each indication market. It also provides the treatment algorithm flow for each three indications. The report examines the global metabolic diseases treatment usage patterns. In addition, the geographical distribution of metabolic diseases and market across the US, the top five countries of Europe and in Japan are provided in the report. The report also includes insights into the metabolic diseases R&D product pipeline and explores the competitive landscape including major players in metabolic disorder therapeutics market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in metabolic disorder therapeutics market.
Scope
- The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the global metabolic disorder therapeutics market for the three indications that includes Diabetes, Obesity and Dyslipidemia.
- Data and analysis on the metabolic disorder therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
- Annualized market data for the metabolic disorder therapeutics market from 2002 to 2010, with forecasts to 2017 for three indications which includes diabetes, obesity and dyslipidemia
- Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.
- Share of the generics in global metabolic disorder therapeutics market and for the market of each indication that is covered in the report.
- Key drivers and restraints that have had a significant impact on the market.
- The competitive landscape of the global metabolic disorder market including top companies benchmarking. The key companies studied in this report are Pfizer Inc., Novo Nordisk, Sanofi, Takeda, Eli Lilly, GlaxoSmithKline and Merck & Co. Inc.
- Key M&A activities and Licensing Agreements that took place in 2009 and 2011 in the metabolic disorder therapeutics market.
Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to -
- Align your product portfolio to the markets with high growth potential.
- Build effective strategies to launch their pipeline products by identifying potential geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Device a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.
- Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.
Companies Mentioned:
Novo Nordisk
Sanofi
Takeda
Eli Lilly
GlaxoSmithKline (GSK)
Merck & Co Inc
Amylin Pharmaceuticals
View the table of contents of this market research report at http://www.reportstack.com/product/48578/metabolic-disorders-therapeutics-market-to-2017-patent-expiry-of-lipitor-in-2011-will-negatively-impact-dyslipidemia-market-value.html
Friday, 7 October 2011
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
Reportstack, provider of premium market research reports announces the addition of Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers market report to its offering
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
Summary
Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers’ provides an in-depth analysis of the current patient recruitment scenario for major indications under dermatology. The report analyzes a number of clinical trials conducted for major indications. It provides information about the total number of clinical trials conducted by phase, geography, major sponsors and clinical trials per year. An analysis of the total number of patients recruited for major indications is given. The report analyzes total number of patients recruited by phase of clinical trial, geography and major sponsors. An analysis of the average number of patients recruited per trial per year for various indications is also given.
Clinical trials are being conducted on dermatological diseases in order to find better treatment options. There has been an increase in the number of clinical trials conducted due to a rise in the prevalence of dermatology disorders. A clinical trial is one of the most critical parts of the drug development process.
Scope
The report analyzes the clinical trial recruitment trends for pharmaceutical companies for various dermatological trials. Its scope includes -
- Insight on clinical trials conducted for major indications of dermatological diseases such as acne vulgaris, atopic dermatitis, candidiasis, herpes zoster and alopecia between 2000 and 2010.
- The status of patient recruitment by geography, sponsor company, year and stage of development.
- Analysis of the average number of patients recruited per trial for major indications per year.
- Analysis of the average number of patients recruited per trial for major indications by stage of development.
- The prevalence population in India, China and Brazil for all major indications from 2010 to 2017.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Identify and understand the status of clinical trials conducted for major dermatology indications from 2000 to 2010.
- Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.
- Identify the prevalence population for major indications until 2017.
- Identify the average number of patients recruited by stage of development and across years for all major indications.
- Identify the indication for which the most trials are conducted and most patients are recruited.
View the table of contents of this market research report at http://www.reportstack.com/product/48580/clinical-trial-recruitment-in-dermatology-most-trials-focus-on-atopic-dermatitis-while-acne-vulgaris-has-highest-patient-numbers.html
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
Summary
Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers’ provides an in-depth analysis of the current patient recruitment scenario for major indications under dermatology. The report analyzes a number of clinical trials conducted for major indications. It provides information about the total number of clinical trials conducted by phase, geography, major sponsors and clinical trials per year. An analysis of the total number of patients recruited for major indications is given. The report analyzes total number of patients recruited by phase of clinical trial, geography and major sponsors. An analysis of the average number of patients recruited per trial per year for various indications is also given.
Clinical trials are being conducted on dermatological diseases in order to find better treatment options. There has been an increase in the number of clinical trials conducted due to a rise in the prevalence of dermatology disorders. A clinical trial is one of the most critical parts of the drug development process.
Scope
The report analyzes the clinical trial recruitment trends for pharmaceutical companies for various dermatological trials. Its scope includes -
- Insight on clinical trials conducted for major indications of dermatological diseases such as acne vulgaris, atopic dermatitis, candidiasis, herpes zoster and alopecia between 2000 and 2010.
- The status of patient recruitment by geography, sponsor company, year and stage of development.
- Analysis of the average number of patients recruited per trial for major indications per year.
- Analysis of the average number of patients recruited per trial for major indications by stage of development.
- The prevalence population in India, China and Brazil for all major indications from 2010 to 2017.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Identify and understand the status of clinical trials conducted for major dermatology indications from 2000 to 2010.
- Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.
- Identify the prevalence population for major indications until 2017.
- Identify the average number of patients recruited by stage of development and across years for all major indications.
- Identify the indication for which the most trials are conducted and most patients are recruited.
View the table of contents of this market research report at http://www.reportstack.com/product/48580/clinical-trial-recruitment-in-dermatology-most-trials-focus-on-atopic-dermatitis-while-acne-vulgaris-has-highest-patient-numbers.html
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Reportstack, provider of premium market research reports announces the addition of Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly market report to its offering
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Summary
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly”, which provides key data, information and analysis of the major trends and issues affecting biomarkers in the drug discovery process. The report provides a comprehensive insight into the history of biomarkers, their uses and efficiency, as well as their limitations. The report also provides a detailed analysis of the biomarkers market’s characterization in terms of its market size, segmentation by use of biomarkers in drug discovery, diagnostics and others and the major market drivers and barriers. The report also looks into the biomarkers pipeline as well as an analysis on the pipeline by indication, phase of development and geography of development. The report also provides a competitive landscape of the market that profiles key market players along with their brief business description, major products and major Mergers & Acquisitions (M&A) and partnership deals. The report also provides detailed analysis of major partnership and M&A deals that have taken place in the biomarkers market in the year 2010 and till May 2011 along with segmentation by deal type, geography and companies. Finally, the report provides the major conclusions about the biomarkers market
Scope
The report analyses the biomarkers in the drug discovery market along with the major forces driving the current market and the potential challenges that can restrain the growth. The scope of the report includes -
- An overview of biomarkers in the drug discovery process along with their use, efficiency and limitations.
- Annualized market data from 2002 and forecast forward to 2017, along with segmentation of the market into drug discovery, diagnostic and others.
- Key market drivers and restraints shaping the biomarkers market.
- Pipeline analysis of the biomarkers, along with segmentation by indication, phase and geography.
- Competitive landscape analysis with profiling of leading companies such as Quest Diagnostics, Vermillion, Amgen, Abbott and Roche.
- Analysis of partnership and M&A deals from 2010 till May 2011, along with segmentation by indication, deal type, geography and companies.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop better strategies for biomarkers research by understanding the market dynamics of the biomarker drug discovery industry.
- Develop market-entry and market expansion strategies by identifying the key areas for high growth and high opportunities.
- Understand the factors shaping the biomarkers drug discovery market.
- Reinforce the R&D pipeline by identifying the key biomarker tests which can provide more accurate and early diagnosis of diseases.
- Identify the key players best positioned to take the advantage of the opportunities in the global biomarkers drug discovery market.
- Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.
Companies Mentioned:
Quest Diagnostics
Life Technologies Corporation
Vermillion
BG Medicine
Menarini
Abbott
Roche
Genentech
Affymetrix
Amgen
View the table of contents of this market research report at http://www.reportstack.com/product/48575/biomarkers-in-drug-discovery-earlier-usage-of-biomarkers-in-optimization-stage-to-reduce-drug-attrition-rate-significantly.html
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Summary
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly”, which provides key data, information and analysis of the major trends and issues affecting biomarkers in the drug discovery process. The report provides a comprehensive insight into the history of biomarkers, their uses and efficiency, as well as their limitations. The report also provides a detailed analysis of the biomarkers market’s characterization in terms of its market size, segmentation by use of biomarkers in drug discovery, diagnostics and others and the major market drivers and barriers. The report also looks into the biomarkers pipeline as well as an analysis on the pipeline by indication, phase of development and geography of development. The report also provides a competitive landscape of the market that profiles key market players along with their brief business description, major products and major Mergers & Acquisitions (M&A) and partnership deals. The report also provides detailed analysis of major partnership and M&A deals that have taken place in the biomarkers market in the year 2010 and till May 2011 along with segmentation by deal type, geography and companies. Finally, the report provides the major conclusions about the biomarkers market
Scope
The report analyses the biomarkers in the drug discovery market along with the major forces driving the current market and the potential challenges that can restrain the growth. The scope of the report includes -
- An overview of biomarkers in the drug discovery process along with their use, efficiency and limitations.
- Annualized market data from 2002 and forecast forward to 2017, along with segmentation of the market into drug discovery, diagnostic and others.
- Key market drivers and restraints shaping the biomarkers market.
- Pipeline analysis of the biomarkers, along with segmentation by indication, phase and geography.
- Competitive landscape analysis with profiling of leading companies such as Quest Diagnostics, Vermillion, Amgen, Abbott and Roche.
- Analysis of partnership and M&A deals from 2010 till May 2011, along with segmentation by indication, deal type, geography and companies.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop better strategies for biomarkers research by understanding the market dynamics of the biomarker drug discovery industry.
- Develop market-entry and market expansion strategies by identifying the key areas for high growth and high opportunities.
- Understand the factors shaping the biomarkers drug discovery market.
- Reinforce the R&D pipeline by identifying the key biomarker tests which can provide more accurate and early diagnosis of diseases.
- Identify the key players best positioned to take the advantage of the opportunities in the global biomarkers drug discovery market.
- Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.
Companies Mentioned:
Quest Diagnostics
Life Technologies Corporation
Vermillion
BG Medicine
Menarini
Abbott
Roche
Genentech
Affymetrix
Amgen
View the table of contents of this market research report at http://www.reportstack.com/product/48575/biomarkers-in-drug-discovery-earlier-usage-of-biomarkers-in-optimization-stage-to-reduce-drug-attrition-rate-significantly.html
Tuesday, 4 October 2011
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
Reportstack, provider of premium market research reports announces the addition of Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers market report to its offering
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market.
The report provides a worldwide strategic overview of the pharmaceutical market, including:
Sales forecast for major product segments: ethical, OTC, generics.
Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.
In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.
The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
The report's major objectives include:
To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the Asia Pacific pharmaceutical market.
To help current suppliers realistically assess their financial, technological and marketing capabilities vis-…-vis the leading competitors.
To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.
To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
View the table of contents of this market research report at http://www.reportstack.com/product/48560/asia-pacific-pharmaceutical-market-strategic-assessments-of-leading-suppliers.html
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market.
The report provides a worldwide strategic overview of the pharmaceutical market, including:
Sales forecast for major product segments: ethical, OTC, generics.
Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.
In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.
The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
The report's major objectives include:
To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the Asia Pacific pharmaceutical market.
To help current suppliers realistically assess their financial, technological and marketing capabilities vis-…-vis the leading competitors.
To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.
To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
View the table of contents of this market research report at http://www.reportstack.com/product/48560/asia-pacific-pharmaceutical-market-strategic-assessments-of-leading-suppliers.html
Monday, 3 October 2011
Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Reportstack, provider of premium market research reports announces the addition of Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 market report to its offering
Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData's new report, "Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global glucose monitoring systems market. The report provides market landscape, competitive landscape and market trends information on the glucose monitoring systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include blood glucose meters, blood glucose test strips, and lancets.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within glucose monitoring systems market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Bayer HealthCare AG, and Abbott Laboratories.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the glucose monitoring systems market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the glucose monitoring systems market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global glucose monitoring systems market and the factors shaping it.
Companies Mentioned
LifeScan, Inc.
F. Hoffmann-La Roche Ltd.
Bayer Healthcare
Abbott Laboratories
Arkray, Inc.
View the table of contents of this market research report at http://www.reportstack.com/product/39179/glucose-monitoring-systems-global-pipeline-analysis-opportunity-assessment-and-market-forecasts-to-2016.html
Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData's new report, "Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global glucose monitoring systems market. The report provides market landscape, competitive landscape and market trends information on the glucose monitoring systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include blood glucose meters, blood glucose test strips, and lancets.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within glucose monitoring systems market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Bayer HealthCare AG, and Abbott Laboratories.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the glucose monitoring systems market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the glucose monitoring systems market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global glucose monitoring systems market and the factors shaping it.
Companies Mentioned
LifeScan, Inc.
F. Hoffmann-La Roche Ltd.
Bayer Healthcare
Abbott Laboratories
Arkray, Inc.
View the table of contents of this market research report at http://www.reportstack.com/product/39179/glucose-monitoring-systems-global-pipeline-analysis-opportunity-assessment-and-market-forecasts-to-2016.html
Asia Pacific Acrylonitrile Industry Outlook to 2015 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Reportstack, provider of premium market research reports announces the addition of Asia Pacific Acrylonitrile Industry Outlook to 2015 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants market report to its offering
Asia Pacific Acrylonitrile Industry Outlook to 2015 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned PlantsSummaryGlobalData's report, "Asia Pacific Acrylonitrile Industry Outlook to 2015 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants" provides an in-depth coverage of Asia Pacific Acrylonitrile industry. The research presents major market trends affecting Acrylonitrile in the region. It provides capacity growth and presents installed capacity by key feedstock, process and technology. In addition, it presents market size, demand and production forecasts, end use demand forecasts, and company shares of major Acrylonitrile producers in the region. The research also provides price trends and trade balance data. Supply and demand scenario for key countries within the region is also included in the report. Overall, the reports present a comprehensive analysis of the specific petrochemical in the region covering all the major parameters.Scope- Acrylonitrile industry supply scenario in the region from 2000 to 2015 consisting of capacity growth, installed plant capacity by key feedstock, production process and technology - Supply and demand outlook in key countries in Asia Pacific from 2000 to 2015- Information of all active and planned petrochemical plants in Asia Pacific with capacity forecasts to 2015- Detailed information on all operating and planned projects covering details such as process, technology, key feedstock and operator and equity details- Acrylonitrile industry market dynamics in Asia Pacific from 2000 to 2015 consisting of market size, demand and production outlook, demand by end use sector, and average prices- Key countries trade balance data from 2000 to 2015 including details on imports, exports, net exports and imports as percentage of demand- Comparison of supply demand scenario in Asia Pacific with other regions in the world- Company snapshots including company overview, business description and information on the current and upcoming petrochemical plants in Asia Pacific - Company shares of key competitors in Asia Pacific and across major countries in the region
Reasons to buy-
Obtain the most up to date information available on the Acrylonitrile industry in Asia Pacific
- Benefit from GlobalData's advanced insight on the Acrylonitrile industry in Asia Pacific
- Identify the macro and micro-economic trends affecting the Acrylonitrile industry in Asia Pacific
- Understand the market positioning of Acrylonitrile producers in Asia Pacific
- Develop market-entry and market expansion strategies
- Benchmark your operations and strategies against the major companies in Asia Pacific
Companies Mentioned
Asahi Kasei Corporation
China National Petroleum Corporation
China Petroleum & Chemical Corporation
Formosa Plastics Group
China Petrochemical Development Corporation (CPDC)
View the table of contents of this market research report at http://www.reportstack.com/product/39393/asia-pacific-acrylonitrile-industry-outlook-to-2015-market-size-company-share-price-trends-capacity-forecasts-of-all-active-and-planned-plants.html
Asia Pacific Acrylonitrile Industry Outlook to 2015 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned PlantsSummaryGlobalData's report, "Asia Pacific Acrylonitrile Industry Outlook to 2015 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants" provides an in-depth coverage of Asia Pacific Acrylonitrile industry. The research presents major market trends affecting Acrylonitrile in the region. It provides capacity growth and presents installed capacity by key feedstock, process and technology. In addition, it presents market size, demand and production forecasts, end use demand forecasts, and company shares of major Acrylonitrile producers in the region. The research also provides price trends and trade balance data. Supply and demand scenario for key countries within the region is also included in the report. Overall, the reports present a comprehensive analysis of the specific petrochemical in the region covering all the major parameters.Scope- Acrylonitrile industry supply scenario in the region from 2000 to 2015 consisting of capacity growth, installed plant capacity by key feedstock, production process and technology - Supply and demand outlook in key countries in Asia Pacific from 2000 to 2015- Information of all active and planned petrochemical plants in Asia Pacific with capacity forecasts to 2015- Detailed information on all operating and planned projects covering details such as process, technology, key feedstock and operator and equity details- Acrylonitrile industry market dynamics in Asia Pacific from 2000 to 2015 consisting of market size, demand and production outlook, demand by end use sector, and average prices- Key countries trade balance data from 2000 to 2015 including details on imports, exports, net exports and imports as percentage of demand- Comparison of supply demand scenario in Asia Pacific with other regions in the world- Company snapshots including company overview, business description and information on the current and upcoming petrochemical plants in Asia Pacific - Company shares of key competitors in Asia Pacific and across major countries in the region
Reasons to buy-
Obtain the most up to date information available on the Acrylonitrile industry in Asia Pacific
- Benefit from GlobalData's advanced insight on the Acrylonitrile industry in Asia Pacific
- Identify the macro and micro-economic trends affecting the Acrylonitrile industry in Asia Pacific
- Understand the market positioning of Acrylonitrile producers in Asia Pacific
- Develop market-entry and market expansion strategies
- Benchmark your operations and strategies against the major companies in Asia Pacific
Companies Mentioned
Asahi Kasei Corporation
China National Petroleum Corporation
China Petroleum & Chemical Corporation
Formosa Plastics Group
China Petrochemical Development Corporation (CPDC)
View the table of contents of this market research report at http://www.reportstack.com/product/39393/asia-pacific-acrylonitrile-industry-outlook-to-2015-market-size-company-share-price-trends-capacity-forecasts-of-all-active-and-planned-plants.html
Advanced Batteries - Global Market Size, Technology Road-Map, Regulations, Competitive Landscape and Pricing Analysis to 2020
Reportstack, provider of premium market research reports announces the addition of Advanced Batteries - Global Market Size, Technology Road-Map, Regulations, Competitive Landscape and Pricing Analysis to 2020 market report to its offering
Advanced Batteries - Global Market Size, Technology Road-Map, Regulations, Competitive Landscape and Pricing Analysis to 2020SummaryThe report provides an in-depth analysis of the global advanced batteries market and gives growth projections up to 2020. The research analyzes key trends, technological road-map and growth opportunities in the global advanced batteries market. Elaborate profiling of major market participants along with detailed analysis of the competitive scenario provides a comprehensive understanding of the global advanced batteries market.Scope- Detailed analysis of the market scenario and growth opportunities- Detailed analysis of market forces influencing technology uptake- Detailed analysis of technology developments- Detailed analysis of major regulations influencing the global market- Competitive analysis of key market participants
Reasons to buy-
Identify key growth and investment opportunities in the global advanced market
- Position yourself to gain the maximum advantage of the market's growth potential
- Understand and respond to your competitors' business structure, strategy and prospects
- Facilitate decision-making based on strong historic and forecast data, deal analysis and recent developments
Companies Mentioned
View the table of contents of this market research report at http://www.reportstack.com/product/39145/advanced-batteries-global-market-size-technology-road-map-regulations-competitive-landscape-and-pricing-analysis-to-2020.html
Advanced Batteries - Global Market Size, Technology Road-Map, Regulations, Competitive Landscape and Pricing Analysis to 2020SummaryThe report provides an in-depth analysis of the global advanced batteries market and gives growth projections up to 2020. The research analyzes key trends, technological road-map and growth opportunities in the global advanced batteries market. Elaborate profiling of major market participants along with detailed analysis of the competitive scenario provides a comprehensive understanding of the global advanced batteries market.Scope- Detailed analysis of the market scenario and growth opportunities- Detailed analysis of market forces influencing technology uptake- Detailed analysis of technology developments- Detailed analysis of major regulations influencing the global market- Competitive analysis of key market participants
Reasons to buy-
Identify key growth and investment opportunities in the global advanced market
- Position yourself to gain the maximum advantage of the market's growth potential
- Understand and respond to your competitors' business structure, strategy and prospects
- Facilitate decision-making based on strong historic and forecast data, deal analysis and recent developments
Companies Mentioned
View the table of contents of this market research report at http://www.reportstack.com/product/39145/advanced-batteries-global-market-size-technology-road-map-regulations-competitive-landscape-and-pricing-analysis-to-2020.html
Subscribe to:
Posts (Atom)